Mass spectrometry and tandem mass spectrometry, alone or after liquid chromatography, for analysis of polymerase chain reaction products in the detection of genomic variation.
The availability of the sequences of entire bacterial and human genomes has opened up tremendous opportunities in biomedical research. The next stage in genomics will include utilizing this information to obtain a clearer understanding of molecular diversity among pathogens (helping improved identification and detection) and among normal and diseased people (e.g. aiding cancer diagnosis). To delineate such differences it may sometimes be necessary to sequence multiple representative genomes. However, often it may be adequate to delineate structural differences between genes among individuals. This may be readily achieved by high-throughput mass spectrometry analysis of polymerase chain reaction products.
Walters
James J
JJ
Department of Microbiology and Immunology, University of South Carolina, School of Medicine, Columbia 29208, USA.
Fox
Karen F
KF
Fox
A
A
D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D014644:Genetic Variation; D016678:Genome; D013058:Mass Spectrometry / Q000379:methods*; D016133:Polymerase Chain Reaction / Q000379:methods*